BST1 and ovarian carcinoma: CD157 is expressed in >90% of epithelial ovarian cancers where high CD157 expression correlates with increased tumor aggressiveness, promotes epithelial-to-mesenchymal transition [22] and is an independent prognostic factor for overall survival [23].